Clinical trials
Terminated Multiple Myeloma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| AbbVie | 1 |
| Autolus Limited | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| GlaxoSmithKline | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Kiadis Pharma | 1 |
| Novartis Pharmaceuticals | 1 |
| Oncopeptides AB | 1 |
| Royal National Orthopaedic Hospital NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 16 |
| Recurrence | 6 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Neoplasms | 2 |
| Neoplasms, Plasma Cell | 2 |
| Graft vs Host Disease | 1 |
| Hematologic Neoplasms | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.